InsiderClue
Stocks · Health care · Orthopedic, Prosthetic & Surgical Appliances & Supplies

ENvue Medical, Inc.

FEED Clue Score51
United States Fiscal year ends December CIK 0001326706
$0.35 -12.52% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.35 −82.50% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 13 Jun 2017. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.2Operating income−2.3Net income−2.8Fiscal year 2017Revenue0.2 +4.4%Operating income−3.1Net income−5.0Fiscal year 2018Revenue0.3 +33.1%Operating income−4.3Net income−4.2Fiscal year 2019Revenue0.5 +66.7%Operating income−5.2Net income−5.8Fiscal year 2020Revenue0.6 +17.5%Operating income−4.7Net income−4.3Fiscal year 2021Revenue1.7 +172.1%Operating income−5.7Net income−14.3Fiscal year 2022Revenue0.8 −55.6%Operating income−5.0Net income−5.4EPS, diluted−3.84Fiscal year 2023Revenue2.3 +203.6%Operating income−3.4Net income−3.7EPS, diluted−23.32Fiscal year 2024Revenue2.6 +12.0%Operating income−3.6Net income−3.7EPS, diluted−137.30Fiscal year 2025Revenue2.6 −0.2%Operating income−22.9Net income−18.2EPS, diluted−26.69
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.2 0.2 0.3 0.5 0.6 1.7 0.8 2.3 2.6 2.6
Growth +4.4% +33.1% +66.7% +17.5% +172.1% −55.6% +203.6% +12.0% −0.2%
Operating income −2.3 −3.1 −4.3 −5.2 −4.7 −5.7 −5.0 −3.4 −3.6 −22.9
Net income −2.8 −5.0 −4.2 −5.8 −4.3 −14.3 −5.4 −3.7 −3.7 −18.2
Growth
EPS, diluted n/a n/a n/a n/a n/a n/a −3.84 −23.32 −137.30 −26.69

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin61.6%Operating margin−1,011.4%Net margin−1,236.2%Free cash flow margin−672.9%Fiscal year 2017Gross margin63.2%Operating margin−1,293.3%Net margin−2,077.4%Fiscal year 2018Gross margin50.3%Operating margin−1,353.1%Net margin−1,306.3%Free cash flow margin−1,118.9%Fiscal year 2019Gross margin53.0%Operating margin−971.9%Net margin−1,093.2%Fiscal year 2020Gross margin34.3%Operating margin−757.5%Net margin−694.4%Free cash flow margin−544.6%Fiscal year 2021Gross margin45.4%Operating margin−335.3%Net margin−842.6%Free cash flow margin−257.8%Fiscal year 2022Gross margin22.2%Operating margin−666.5%Net margin−724.5%Free cash flow margin−935.9%Fiscal year 2023Gross margin67.3%Operating margin−150.5%Net margin−162.5%Free cash flow margin−157.8%Fiscal year 2024Gross margin59.0%Operating margin−140.0%Net margin−144.8%Free cash flow margin−98.5%Fiscal year 2025Gross margin6.0%Operating margin−896.6%Net margin−712.3%Free cash flow margin−369.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 61.6% 63.2% 50.3% 53.0% 34.3% 45.4% 22.2% 67.3% 59.0% 6.0%
Operating margin −1,011.4% −1,293.3% −1,353.1% −971.9% −757.5% −335.3% −666.5% −150.5% −140.0% −896.6%
Net margin −1,236.2% −2,077.4% −1,306.3% −1,093.2% −694.4% −842.6% −724.5% −162.5% −144.8% −712.3%
Free cash flow margin −672.9% n/a −1,118.9% n/a −544.6% −257.8% −935.9% −157.8% −98.5% −369.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−1.5Capital expenditure−0.0Free cash flow−1.5Fiscal year 2017Operating cash flow−2.2Fiscal year 2018Operating cash flow−3.6Capital expenditure−0.0Free cash flow−3.6Fiscal year 2019Operating cash flow−3.9Fiscal year 2020Operating cash flow−3.4Capital expenditure−0.0Free cash flow−3.4Fiscal year 2021Operating cash flow−4.4Capital expenditure−0.0Free cash flow−4.4Fiscal year 2022Operating cash flow−7.0Capital expenditure−0.0Free cash flow−7.0Fiscal year 2023Operating cash flow−3.6Capital expenditure−0.0Free cash flow−3.6Fiscal year 2024Operating cash flow−2.5Capital expenditure−0.0Free cash flow−2.5Fiscal year 2025Operating cash flow−9.4Capital expenditure−0.1Free cash flow−9.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −1.5 −2.2 −3.6 −3.9 −3.4 −4.4 −7.0 −3.6 −2.5 −9.4
Capital expenditure −0.0 n/a −0.0 n/a −0.0 −0.0 −0.0 −0.0 −0.0 −0.1
Free cash flow −1.5 n/a −3.6 n/a −3.4 −4.4 −7.0 −3.6 −2.5 −9.4
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash0.1Shareholders’ equity−2.5Fiscal year 2017Cash4.4Shareholders’ equity3.6Fiscal year 2018Cash0.9Shareholders’ equity0.5Fiscal year 2019Cash1.3Shareholders’ equity1.3Fiscal year 2020Cash7.1Shareholders’ equity2.4Fiscal year 2021Cash7.7Shareholders’ equity6.3Fiscal year 2022Cash2.7Shareholders’ equity3.2Fiscal year 2023Cash3.3Shareholders’ equity4.0Fiscal year 2024Cash0.8Shareholders’ equity0.6Fiscal year 2025Cash4.2Shareholders’ equity33.5
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.1 4.4 0.9 1.3 7.1 7.7 2.7 3.3 0.8 4.2
Shareholders’ equity −2.5 3.6 0.5 1.3 2.4 6.3 3.2 4.0 0.6 33.5

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Operations
−1.5 −2.2 −3.6 −3.9 −3.4 −4.4 −7.0 −3.6 −2.5 −9.4
Growth
n/a n/a 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9
Investment
−0.0 n/a −0.0 n/a −0.0 −0.0 −0.0 −0.0 −0.0 −0.1
calc −1.5 n/a −3.6 n/a −3.4 −4.4 −7.0 −3.6 −2.5 −9.4
Growth
calc n/a n/a n/a n/a n/a n/a −4.96 −22.65 −93.35 −15.01
−0.0 n/a −0.0 n/a −0.0 −0.0 −0.0 −0.0 −0.0 0.1
Financing
0.0 6.4 0.1 4.3 9.5 4.6 2.1 4.2 0.0 12.8

† The diluted share count jumps at 2023 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.